Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Sacks

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Journal of Gastroenterology and Hepatology|March 10, 2021
Estimating the number of new hepatitis C infections in Australia in 2015, prior to the scale-up of direct-acting antiviral treatmentAnna Y Palmer, Anna Wilkinson, Campbell Aitken, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 26, 2021
Brief Report: Low Incidence of Hepatitis C Among a Cohort of HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP) in Melbourne, Australia, and the Contribution of Sexual TransmissionVincent J Cornelisse, Michael W Traeger, Edwina J Wright, et al.
Plos One|October 31, 2012
Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugsRachel Sacks-Davis, Galina Daraganova, Campbell Aitken, et al.
The Journal of Infectious Diseases|March 30, 2012
The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study designPeter Vickerman, Jason Grebely, Gregory J Dore, et al.
Emerging Infectious Diseases|March 10, 2022
Mathematical Modeling for Removing Border Entry and Quarantine Requirements for COVID-19, VanuatuCaroline van Gemert, Len Tarivonda, Posikai Samuel Tapo, et al.
Open Forum Infectious Diseases|August 18, 2023
Incidence and Prevalence of Hepatitis C Virus Among HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP): A Systematic Review and Meta-analysisMichael W Traeger, Brendan L Harney, Rachel Sacks-Davis, et al.
Hepatitis Monthly|February 6, 2014
Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug UsersJacqueline K Flynn, Rachel Sacks-Davis, Peter Higgs, et al.
Cancers|August 10, 2024
Improving Hepatocellular Carcinoma Surveillance Outcomes in Patients with Cirrhosis after Hepatitis C Cure: A Modelling StudyJacob Cumming, Nick Scott, Jessica Howell, et al.
Plos One|November 19, 2013
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort studyRachel Sacks-Davis, Campbell K Aitken, Peter Higgs, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 1, 2019
People who inject drugs in Bangladesh - The untold burden!Sharful I Khan, Md Masud Reza, Suzanne M Crowe, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Journal of Gastroenterology and Hepatology|March 10, 2021
Estimating the number of new hepatitis C infections in Australia in 2015, prior to the scale-up of direct-acting antiviral treatmentAnna Y Palmer, Anna Wilkinson, Campbell Aitken, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 26, 2021
Brief Report: Low Incidence of Hepatitis C Among a Cohort of HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP) in Melbourne, Australia, and the Contribution of Sexual TransmissionVincent J Cornelisse, Michael W Traeger, Edwina J Wright, et al.
Plos One|October 31, 2012
Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugsRachel Sacks-Davis, Galina Daraganova, Campbell Aitken, et al.
The Journal of Infectious Diseases|March 30, 2012
The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study designPeter Vickerman, Jason Grebely, Gregory J Dore, et al.
Emerging Infectious Diseases|March 10, 2022
Mathematical Modeling for Removing Border Entry and Quarantine Requirements for COVID-19, VanuatuCaroline van Gemert, Len Tarivonda, Posikai Samuel Tapo, et al.
Open Forum Infectious Diseases|August 18, 2023
Incidence and Prevalence of Hepatitis C Virus Among HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP): A Systematic Review and Meta-analysisMichael W Traeger, Brendan L Harney, Rachel Sacks-Davis, et al.
Hepatitis Monthly|February 6, 2014
Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug UsersJacqueline K Flynn, Rachel Sacks-Davis, Peter Higgs, et al.
Cancers|August 10, 2024
Improving Hepatocellular Carcinoma Surveillance Outcomes in Patients with Cirrhosis after Hepatitis C Cure: A Modelling StudyJacob Cumming, Nick Scott, Jessica Howell, et al.
Plos One|November 19, 2013
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort studyRachel Sacks-Davis, Campbell K Aitken, Peter Higgs, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 1, 2019
People who inject drugs in Bangladesh - The untold burden!Sharful I Khan, Md Masud Reza, Suzanne M Crowe, et al.
Pageof 12